Details of the Drug

General Information of Drug (ID: DMFJAG7)

Drug Name
NLS-001
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Phase 2 [1]
Cross-matching ID
TTD ID
D8DYX3

References

1 Clinical pipeline report, company report or official report of NLS Pharmaceutics